Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check5 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-restricted notice and a basic footer. This indicates that the study record is presently inaccessible.SummaryDifference21%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, signaling a small update to the page’s version. This change does not alter the content or how users interact with the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page. This appears to be a small maintenance update and does not modify study details or user-facing features.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the page content. This appears to be a maintenance update that does not modify study data or eligibility details.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. No study content or parameters appear to be changed.SummaryDifference0.0%

- Check91 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a new version of the study record page has been published.SummaryDifference0.0%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.